Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-REST Antibody (R3S09)

Catalog #:   RHG41402 Specific References (49) DATASHEET
Host species: Mouse
Isotype: IgG2a
Applications: WB
Accession: Q13127
Overview

Catalog No.

RHG41402

Species reactivity

Human

Host species

Mouse

Isotype

IgG2a

Clonality

Monoclonal

Tested applications

WB: 1:500-1:1000

Target

RE1-silencing transcription factor, Neural-restrictive silencer factor, NRSF, X2 box repressor, XBR, REST

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

Q13127

Applications

WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3S09

Data Image
  • Western blot
    Western blot analysis using REST mouse mAb against HeLa lysate
References

Direct Interleukin-6 Inhibition Blunts Arterial Thrombosis by Reducing Collagen-Mediated Platelet Activation., PMID:40534557

Detection of previously undiagnosed or lost to follow-up hepatitis C infections by implementing an opportunistic screening in an emergency department., PMID:40467412

Latin American RAND/UCLA modified Delphi consensus recommendations for management and treatment of adult MOGAD patients in clinical practice., PMID:40435656

Immunocytokines and cytokine neutralization for cancer immunotherapy., PMID:40425444

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease., PMID:40417267

[Preparation and application of bovine CD4 monoclonal antibodies]., PMID:40415625

Low-Dose Anti-PD1 Immune Checkpoint Inhibitors in Relapsed/Refractory Hodgkin Lymphoma: A Systematic Review., PMID:40403200

Nanomedicine for targeting brain Neurodegeneration: Critical barriers and circadian rhythm Considerations., PMID:40383234

Epitope mapping of SARS-CoV-2 Spike protein using naturally-acquired immune responses to develop monoclonal antibodies., PMID:40346118

Immunogenicity and Protective Efficacy of Five Vaccines Against Highly Pathogenic Avian Influenza Virus H5N1, Clade 2.3.4.4b, in Fattening Geese., PMID:40333332

Histopathological and immunohistochemical characteristics of chordae tendineae affected by degenerative processes in canine myxomatous mitral valve disease., PMID:40327166

Long-term effects of COVID-19 in patients with primary immunodeficiency: An IPOPI worldwide survey., PMID:40316182

Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE binding., PMID:40311815

Food allergy endotypes revisited., PMID:40306493

Characteristics of hepatitis B virus surface protein and occult hepatitis B infection in infants with immunoprophylaxis failure from Indonesia., PMID:40305978

Complement dysregulation at lymphatics., PMID:40300720

Differential immunogenicity in people living with HIV with varying CD4 levels after bivalent mRNA COVID-19 booster vaccination., PMID:40299994

In situ detection of activation of CAPN3, a responsible gene product for LGMDR1, in mouse skeletal myotubes., PMID:40280419

Free-IgE as a Predictor of Responsiveness to Omalizumab in Oral Corticosteroid-Dependent Asthma Patients., PMID:40243423

Clinical factors predicting nemolizumab response in atopic dermatitis., PMID:40242149

Phase 2 trial of perioperative chemo-immunotherapy for gastro-esophageal adenocarcinoma: The role of M2 macrophage landscape in predicting response., PMID:40239627

Small extracellular vesicle miRNAs as biomarkers for predicting antitumor efficacy in lung adenocarcinoma treated with chemotherapy and checkpoint blockade., PMID:40230863

Structural and antigen-binding surface definition of an anti-CD93 monoclonal antibody for the treatment of degenerative vascular eye diseases., PMID:40228767

Assessment of myocardial dysfunction of patients with systemic lupus erythematosus based on myocardial perfusion imaging and analysis of potential influencing factors., PMID:40228498

The physiological limits of bispecific monoclonal antibody tissue targeting specificity., PMID:40223272

Endotypes of chronic spontaneous urticaria and angioedema., PMID:40220911

Immunohistochemical expression of PDL1 and Ki67 in glioma and its correlation with treatment and overall survival., PMID:40214367

Clinical features and risk factors of flare in anti-synthetase syndrome., PMID:40205268

Improving ultrasound image classification accuracy of liver tumors using deep learning model with hepatitis virus infection information., PMID:40205118

Serological data indicate a widespread presence of rabbit haemorrhagic disease in rabbit farms in Algeria., PMID:40185862

DNA origami signal amplification in lateral flow immunoassays., PMID:40185718

Fulminant Clostridioides difficile Infection: A Journey into the Unknown!, PMID:40185558

Pre-clinical strategies and emerging technologies driving advances in the alpha-gal syndrome., PMID:40180833

PD-L1 expression in multiple myeloma myeloid derived suppressor cells., PMID:40180451

Functional insights of an uncommon hypomorphic variant in IL2RG as a monogenic cause of CVID-like disease with antibody deficiency and T CD4 lymphopenia., PMID:40170851

Clinical significance of anti-Ro and Anti-La antibodies: The role of isolated anti-La., PMID:40168598

Allosteric Control and Glycan Shielding Adaptations in the SARS-CoV-2 Spike from Early to Peak Virulence., PMID:40161746

CD 14 Expression in Urothelial Carcinoma of The Urinary Bladder (Histopathological and Immunohistochemical Study)., PMID:40156405

Adding a Twist to Lateral Flow Immunoassays: A Direct Replacement of Antibodies with Helical Affibodies, from Selection to Application., PMID:40135773

Clinical efficacy and mechanisms of biologics for chronic rhinosinusitis with nasal polyps., PMID:40132672

Prevalence and Circulating Serotypes of Dengue in Bastar, Chhattisgarh: A Cross-Sectional Study., PMID:40123828

Comparison of the EPOS 2020 and POLINA 2.0 guidelines for indicating biologic treatment in adults with chronic rhinosinusitis and nasal polyps., PMID:40122169

Immunoelectrochemical assessment of human IgE in non-invasive samples of allergic individuals using PdNCs-labelled antibodies., PMID:40100481

Diagnosis, Characteristics, and Outcome of Selective Anti-polysaccharide Antibody Deficiencies In A Retrospective Cohort of 55 Adult Patients., PMID:40097777

[Mechanism of the pretreatment with electroacupuncture of "biaoben acupoint combination" for regulating cardiomyocyte mitochondrial fission in the rats of myocardial ischemia-reperfusion injury]., PMID:40097217

ANCA Negative Vasculitis Manifesting as Pulmonary-Renal Syndrome in a Patient with Chronic Osteomyelitis., PMID:40087953

Soluble Factors and Mechanisms Regulated by Sialylated IgG Signaling., PMID:40084926

Sero-Surveillance to Evaluate Trends in the Transmission of SARS-CoV-2 in a Central Indian District., PMID:40084305

A novel dominant-negative variant of IRF8 in a mother and son: Clinical, phenotypic and biological characteristics., PMID:40072380

Datasheet

Document Download

Anti-REST Antibody (R3S09).pdf

 

$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-REST Antibody (R3S09) [RHG41402]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only